Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment
Phase 4
Completed
- Conditions
- Breast Neoplasm
- Interventions
- Device: MRI
- Registration Number
- NCT01859936
- Lead Sponsor
- Karolinska University Hospital
- Brief Summary
The study is a prospective randomised multicenter trial assessing the additional value of breast MRI in women under 56 years of age with newly diagnosed breast cancer. Will preoperative breast MRI change treatment regimen? Will preoperative breast MRI reduce the number of primary surgeries? Will preoperative breast MRI increase the rate of mastectomies? Will preoperative breast MRI be cost effective?
- Detailed Description
Completed: the study has concluded normally; participants are no longer being examined or treated (i.e., last patient's last visit has occurred)
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 440
Inclusion Criteria
- Women under 56 years of age
- Newly diagnosed breast cancer
- Swedish or English speaking
Exclusion Criteria
- Claustrophobia
- Pregnancy
- Renal failure
- Metal items in patients
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description preoperative breast MRI MRI The intervention is that preoperative MRI breast will be performed in women under 56 years with newly diagnosed breast cancer
- Primary Outcome Measures
Name Time Method Change of treatment plan 14 days Did breast magnetic resonance imaging add information about the tumour that changed primary treatment plan
- Secondary Outcome Measures
Name Time Method Did breast magnetic resonance imaging reduce the number of reoperation during primary management 6 months Did breast magnetic resonance imaging increase the number of mastectomies 6 months Did breast magnetic resonance imaging affect cost 6 months
Trial Locations
- Locations (1)
Karolinska Univeristy Hospital
🇸🇪Stockholm, Sweden